Analysis of Unsatisfactory Consequences of Erysipelas Treatment
Abstract
Goal. Find out the cause of unsatisfactory treatment outcomes in patients with destructive forms of erysipelas in the general population.
Materials and methods. Retrospectively and prospectively analyzed 284 case histories of patients who were hospitalized in the center of purulent - septic surgery KNP "City Hospital G3" Zaporozhye for the period 2016-2022.
Results. It was found that most often the local focus was localized on the upper and lower extremities. The most common clinical manifestations of intoxication in bullous and phlegmonous forms of erysipelas were: general weakness, hyperthermia, muscle pain. In the necrotic form of erysipelas, patients showed signs of severe intoxication with nausea, vomiting and confusion. In the complex treatment of patients with erysipelas, the main place belongs to the early surgical treatment of the area of the pathological process and antibiotic therapy (ABT). Determination of serum procalcitonin allows to assess the progression and generalization of the process and is a sensitive test for the effectiveness of treatment.
Conclusions. Radical surgery and timely targeted ABT are key elements of success in the treatment of surgical forms of erysipelas and are not subject to revision. The main causes of unsatisfactory consequences in patients with erysipelas are: aggravation of the disease at the time of hospitalization by septic shock and multiple organ failure, severe decompensated comorbidities. Procalcitonin is a diagnostic marker that can predict the development of sepsis.
Key words: erysipelas, unsatisfactory treatment consequences, procalcitonin.
References
Brazhnik EA, Ostroushko AP. Rozhistoe vospalenie v khirurgicheskoy praktike. Nauchnoye obozreniye. Meditsinskiye nauki. 2016; 4: 14-17.
Dykyi BM, Kondryn OYe, Farbishevskyi VV et al. Udoskonalennia kompleksnoi terapii khvorykh na beshykhu. Medytsyna transportu Ukrainy. 2011; 2: 88-90.
Vasylevska LA. Mortality in necrotic form of erysipelas. Suchasni medychni tekhnolohii. 2021; 3(50): 19-21. [Article in Ukrainian]. Available from: https://doi.org/10.34287/MMT.3(50).2021.4
Shapoval SD, Vasylevska LA. Vykorystannia prokaltsytoninu u khvorykh na khirurhichni formy beshykhy. Medychni perspektyvy. 2021; 26 (1): 196-200. Available from: https://doi.org/10.26641/2307-0404.2021.1.228011
Shapoval SD, Vasylevska LA, Vorontsova LL. Vykorystannia imunokorehuiuchoi terapii v kompleksnomu likuvanni khirurhichnykh form beshykhy. Klinichna khirurhiya. 2021; 5-6(88): 53-55. Available from: https://doi.org/10.26779/2522-1396.2021.5-6.53
Saka B, Kombate K, Mouhari-Toure A. et al. Bacterial dermohypodermis and necrotizing fascitis: 104 case series from Togo. Med. Trop. 2011; 71(2): 162-164. Available from: https://doi.org/:10.19080/OAJS.2018.09.555772
Shimizu T, Tokuda Y. Necrotizing fasciitis. Intern. Med. 2010; 49(12): 1051-1057. Available from: https://doi.org/10.2169/internalmedicine.49.2964
Copyright (c) 2022 Serhii Shapoval, Larysa Vasylevska
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
